PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
JAZZ vs. MKL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between JAZZ and MKL is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

JAZZ vs. MKL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jazz Pharmaceuticals plc (JAZZ) and Markel Corporation (MKL). The values are adjusted to include any dividend payments, if applicable.

200.00%300.00%400.00%500.00%600.00%700.00%NovemberDecember2025FebruaryMarchApril
520.64%
252.36%
JAZZ
MKL

Key characteristics

Sharpe Ratio

JAZZ:

-0.20

MKL:

0.66

Sortino Ratio

JAZZ:

-0.08

MKL:

1.16

Omega Ratio

JAZZ:

0.99

MKL:

1.15

Calmar Ratio

JAZZ:

-0.12

MKL:

0.94

Martin Ratio

JAZZ:

-0.96

MKL:

2.69

Ulcer Index

JAZZ:

6.10%

MKL:

5.69%

Daily Std Dev

JAZZ:

29.56%

MKL:

23.19%

Max Drawdown

JAZZ:

-96.90%

MKL:

-61.32%

Current Drawdown

JAZZ:

-42.99%

MKL:

-16.35%

Fundamentals

Market Cap

JAZZ:

$6.68B

MKL:

$21.90B

EPS

JAZZ:

$8.65

MKL:

$199.35

PE Ratio

JAZZ:

12.72

MKL:

8.64

PEG Ratio

JAZZ:

0.38

MKL:

4.43

Total Revenue (TTM)

JAZZ:

$3.17B

MKL:

$12.15B

Gross Profit (TTM)

JAZZ:

$2.79B

MKL:

$12.15B

EBITDA (TTM)

JAZZ:

$977.99M

MKL:

$2.55B

Returns By Period

In the year-to-date period, JAZZ achieves a -10.65% return, which is significantly lower than MKL's -0.19% return. Over the past 10 years, JAZZ has underperformed MKL with an annualized return of -4.86%, while MKL has yielded a comparatively higher 8.23% annualized return.


JAZZ

YTD

-10.65%

1M

-20.73%

6M

0.60%

1Y

-5.48%

5Y*

0.90%

10Y*

-4.86%

MKL

YTD

-0.19%

1M

-8.97%

6M

7.44%

1Y

14.15%

5Y*

12.87%

10Y*

8.23%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

JAZZ vs. MKL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JAZZ
The Risk-Adjusted Performance Rank of JAZZ is 4444
Overall Rank
The Sharpe Ratio Rank of JAZZ is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of JAZZ is 4242
Sortino Ratio Rank
The Omega Ratio Rank of JAZZ is 4242
Omega Ratio Rank
The Calmar Ratio Rank of JAZZ is 5050
Calmar Ratio Rank
The Martin Ratio Rank of JAZZ is 3737
Martin Ratio Rank

MKL
The Risk-Adjusted Performance Rank of MKL is 8080
Overall Rank
The Sharpe Ratio Rank of MKL is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of MKL is 7676
Sortino Ratio Rank
The Omega Ratio Rank of MKL is 7575
Omega Ratio Rank
The Calmar Ratio Rank of MKL is 8787
Calmar Ratio Rank
The Martin Ratio Rank of MKL is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

JAZZ vs. MKL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Jazz Pharmaceuticals plc (JAZZ) and Markel Corporation (MKL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for JAZZ, currently valued at -0.20, compared to the broader market-2.00-1.000.001.002.00
JAZZ: -0.20
MKL: 0.66
The chart of Sortino ratio for JAZZ, currently valued at -0.08, compared to the broader market-6.00-4.00-2.000.002.004.00
JAZZ: -0.08
MKL: 1.16
The chart of Omega ratio for JAZZ, currently valued at 0.99, compared to the broader market0.501.001.502.00
JAZZ: 0.99
MKL: 1.15
The chart of Calmar ratio for JAZZ, currently valued at -0.12, compared to the broader market0.001.002.003.004.00
JAZZ: -0.12
MKL: 0.94
The chart of Martin ratio for JAZZ, currently valued at -0.96, compared to the broader market-10.000.0010.0020.00
JAZZ: -0.96
MKL: 2.69

The current JAZZ Sharpe Ratio is -0.20, which is lower than the MKL Sharpe Ratio of 0.66. The chart below compares the historical Sharpe Ratios of JAZZ and MKL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.20
0.66
JAZZ
MKL

Dividends

JAZZ vs. MKL - Dividend Comparison

Neither JAZZ nor MKL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

JAZZ vs. MKL - Drawdown Comparison

The maximum JAZZ drawdown since its inception was -96.90%, which is greater than MKL's maximum drawdown of -61.32%. Use the drawdown chart below to compare losses from any high point for JAZZ and MKL. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-42.99%
-16.35%
JAZZ
MKL

Volatility

JAZZ vs. MKL - Volatility Comparison

Jazz Pharmaceuticals plc (JAZZ) has a higher volatility of 13.35% compared to Markel Corporation (MKL) at 7.82%. This indicates that JAZZ's price experiences larger fluctuations and is considered to be riskier than MKL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
13.35%
7.82%
JAZZ
MKL

Financials

JAZZ vs. MKL - Financials Comparison

This section allows you to compare key financial metrics between Jazz Pharmaceuticals plc and Markel Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab